Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human γδ T lymphocytes

Cellular Immunology

Volumn 215, Issue 1, 2002, Pages 32-44

  Rothenfusser, Simon ^a   Buchwald, Armin ^b   Kock, Sylvia ^b   Ferrone, Soldano ^c   Fisch, Paul ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

T cell; Daudi; HLA class I; INMR; Killer cell inhibitory receptors; MHC class I; V 9 V 2 T cell

Indexed keywords

BETA 2 MICROGLOBULIN; CELL RECEPTOR; COMPLEMENTARY DNA; HLA ANTIGEN CLASS 1;

ALLELE; ANTIGEN EXPRESSION; ARTICLE; BLOOD CELL; CELL ASSAY; CELL CLONE; CELL LINE; CELL POPULATION; CELL PROLIFERATION; CELL SPECIFICITY; CELL SURFACE; CELL TYPE; CONFORMATION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DAUDI CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KILLER CELL; MOLECULAR BIOLOGY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN TRANSPORT; T LYMPHOCYTE; TARGET CELL;

ALLELES; BETA 2-MICROGLOBULIN; CELLS, CULTURED; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN VARIABLE REGION; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0036343229     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-8749(02)00001-1     Document Type: Article

References (55)

1. Structural and serological heterogeneity of γ/δ T cell antigen receptor expression in thymus and peripheral blood
2. Evidence for extrathymic changes in the T cell receptor γδ repertoire
3. γδ cells
4. γδ cells: A right time and a right place for a conserved third way of protection
5. Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands
6. Natural and synthetic non-peptide antigens recognized by human γδ T cells
7. Human Vγ9-Vδ9 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites
8. + human cytotoxic T lymphocytes
9. Recognition and destruction of virus-infected cells by human γδ CTL
10. γδ T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis
11. Recognition by human Vγ9/Vδ2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells
12. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells
13. Vγ2Vδ9 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer
14. 2-microglobulin in Daudi cells: Active gene but inactive messenger RNA
15. 2-microglobulin mRNA in Daudi cells: Induction by interferon
16. Receptors for HLA class-I molecules in human natural killer cells
17. + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations
18. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes
19. NK cell receptors
20. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
21. 2-microglobulin gene
22. Somatic cell hybrids between human lymphoma lines. III. Surface markers
23. 2-microglobulin gene is mutated in a human colon cancer cell line (HCT) deficient in the expression of HLA class I antigens on the cell surface
24. 2m gene expression
25. The HLA-A, B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon
26. Production of human cells expressing individual transferred HLA-A, -B, -C genes using an HLA-A, -B, -C null human cell line
27. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vγ9/Vδ2 T cells in tumor immunity
28. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus
29. Structural heterogeneity in HLA-B70, a high-frequency antigen of black populations
30. HLA class I nucleotide sequences, 1995
31. The HLA-A, B, C genotype of the class I negative cell line Daudi reveals novel HLA-A and -B alleles
32. 2-microglobulin controls the expression of transfected human class I genes
33. 2-microglobulin and HLA class I heavy chains results in serologically detectable conformational changes of both chains
34. 2-microglobulin
35. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
36. The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand
37. Recognition by human Vγ9/Vδ2 T cells of melanoma cells upon fusion with Daudi cells
38. Control of self-reactive cytotoxic T lymphocytes expressing γδ T cell receptors by natural killer inhibitory receptors
39. Phenotypic and cytokine analysis of human peripheral blood γδ T cells expressing NK cell receptors
40. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive Vγ9Vδ9 T lymphocytes
41. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition
42. Natural T cells in the human liver: Cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Vα24-Jα Q and γδ T cell receptor bearing cells
43. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
44. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes
45. Inhibitory MHC class I receptors on γδ T cells in tumour immunity and autoimmunity
46. Human NK-cell receptors
47. MICA engagement by human Vγ2Vδ9 T cells enhances their antigen-dependent effector function
48. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
49. An activating immunoreceptor complex formed by NKG2D and DAP10
50. Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin
51. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
52. Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells
53. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors
54. Loss of HLA class I antigens by melanoma cells: Molecular mechanisms, functional significance and clinical relevance
55. Viruses use stealth technology to escape from the host immune system